News and media

Get the latest news and updates, and access our press kit.

twiist opening animation

Read ourpress releases

Sequel Presents Pivotal Trial of the twiist™ Automated Insulin Delivery System in Adults with Insulin-Treated Type 2 Diabetes at the ADA 86th Scientific Sessions

Investigational study marks Sequel’s first pivotal data in type 2 diabetes, the largest population on insulin therapy and one of the most under-served by automated insulin delivery

Sequel Brings twiist™ Nationwide, Redefining Automated Insulin Delivery Category with Industry-First Innovation

Full launch of twiist™ AID system powered by Tidepool brings first-ever combination of personalized insulin automation, innovative delivery technology, and CGM interoperability to type 1 diabetes management.

Sequel Med Tech Statement Regarding Independent Investigation of Board Member Dean Kamen

Investigation and risk assessment by external independent law firm hired by a Special Committee of the Board of Directors found no evidence of wrong doing or inappropriate conduct by Dean Kamen

Explore our press kit

Interested in featuring us?

Access our press kit for high-res logos, photos, and more information about our company and flagship product, twiist™.

Want to know more?

Submit a press inquiry through our contact form.